rs10336
Variant in the CXCL9 gene (C-X-C Motif Chemokine Ligand 9)
rs10336 is a single nucleotide polymorphism (SNP) in the CXCL9 gene, involved in interferon-induced chemokine signaling. Variants at this position have been studied in relation to immune function, metabolism, and chronic illness.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is the rs10336 variant?
rs10336 is a SNP (single nucleotide polymorphism) in the CXCL9 (C-X-C Motif Chemokine Ligand 9) gene. It belongs to the Chemokine category and is part of the Chemokines biological cluster. CXCL9 encodes an interferon-gamma-induced chemokine (MIG) that recruits Th1 cells and NK cells expressing CXCR3.
Biological role and pathway
This variant sits within the CXCL9 gene, which is involved in the interferon-induced chemokine signaling pathway. Genes within the Chemokines cluster work together to maintain balanced function across interconnected biological systems.
Variants in genes within this pathway may influence an individual's predisposition to altered function — particularly under conditions of physiological stress such as viral infection or prolonged illness.
rs10336 and Long COVID / ME-CFS research
Elevated CXCL9 reflects ongoing interferon-gamma signaling and T cell trafficking associated with persistent immune activation in Long COVID.
This information is based on published research and does not constitute medical advice. See references below.
Parent gene: CXCL9
rs10336 is one of 1 known variant in the CXCL9 gene. To understand the full biological context of this variant, explore the parent gene page.
View CXCL9 gene page →Conditions studied in relation to rs10336
Research into CXCL9 variants including rs10336 has explored associations with the following conditions. These are areas of scientific investigation and do not imply causation.
Genetic insights from DNA data
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include CXCL9 and the rs10336 variant.
The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.
Frequently asked questions
What is the rs10336 variant in the CXCL9 gene?
rs10336 is a single nucleotide polymorphism (SNP) located in the CXCL9 (C-X-C Motif Chemokine Ligand 9) gene, which is involved in interferon-induced chemokine signaling. CXCL9 encodes an interferon-gamma-induced chemokine (MIG) that recruits Th1 cells and NK cells expressing CXCR3.
How may the rs10336 variant relate to Long COVID or ME/CFS?
Elevated CXCL9 reflects ongoing interferon-gamma signaling and T cell trafficking associated with persistent immune activation in Long COVID.
Can a consumer DNA test detect the rs10336 variant?
Many consumer DNA tests such as 23andMe, AncestryDNA, and MyHeritage genotype common SNPs. ChronicDNA analyses your raw DNA file and reports on variants studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.
Find out if you carry the rs10336 variant
Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
References
The following publications were used in compiling the research context for CXCL9 and its variants. This is not an exhaustive literature review.
- [1]PMID: 33153018
- [2]Nature Genetics
- [3]Journal of Clinical Investigation